Ananda Sankar Bandyopadhyay (A S Bandyopadhyay, Ananda S Bandyopadhyay)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

PLOS global public health

Pathogens (Basel, Switzerland)

The Pediatric infectious disease journal

Journal of the Pediatric Infectious Diseases Society

Bill and Melinda Gates Foundation

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Bill and Melinda Gates Foundation

United States

Senior Program Officer :: Polio

Rhode Island Government

United States

Public Health Epidemiologist :: Department of Health

Harvard School of Public Health

United States

Research Fellow :: Global Health

World Health Organization - National Polio Surveillance Project

India

Surveillance Medical Officer

Publications

Ananda Sankar Bandyopadhyay, Rachel M Burke, Kaija M Hawes
Polio Eradication: Status, Struggles and Strategies. The Pediatric infectious disease journal (2024)
Feyrouz Damji Kurji, Ananda Sankar Bandyopadhyay, Simona Zipursky, Laura V Cooper, Chris Gast, Margaret Toher, Ralf Clemens, Sue Ann Costa Clemens, Rayasam Prasad, Adriansjah Azhari
Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency. Pathogens (Basel, Switzerland) 13 (4) (2024)
Ananda Sankar Bandyopadhyay, Laura V Cooper, Simona Zipursky
One billion doses and WHO prequalification of nOPV2: Implications for the global polio situation and beyond. PLOS global public health 4 (2) (2024)
Ananda Sankar Bandyopadhyay, Laura V Cooper, Simona Zipursky
One billion doses and WHO prequalification of nOPV2: Implications for the global polio situation and beyond. PLOS global public health 4 (2) (2024)
Feyrouz Damji Kurji, Ananda Sankar Bandyopadhyay, Simona Zipursky, Laura V Cooper, Chris Gast, Margaret Toher, Ralf Clemens, Sue Ann Costa Clemens, Rayasam Prasad, Adriansjah Azhari
Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency. Pathogens (Basel, Switzerland) 13 (4) (2024)
Feyrouz Damji Kurji, Ananda Sankar Bandyopadhyay, Simona Zipursky, Laura V Cooper, Chris Gast, Margaret Toher, Ralf Clemens, Sue Ann Costa Clemens, Rayasam Prasad, Adriansjah Azhari
Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency. Pathogens (Basel, Switzerland) 13 (4) (2024)
Ananda Sankar Bandyopadhyay, Laura V Cooper, Simona Zipursky
One billion doses and WHO prequalification of nOPV2: Implications for the global polio situation and beyond. PLOS global public health 4 (2) (2024)
Ananda Sankar Bandyopadhyay, Rachel M Burke, Kaija M Hawes
Polio Eradication: Status, Struggles and Strategies. The Pediatric infectious disease journal 43 (6) (2024)
Arend Voorman, Hil Lyons, Faisal Shuab, Usman S Adamu, Charles Korir, Tesfaye Erbeto, Ananda Sankar Bandyopadhyay, Samuel Okiror
Evaluation of novel oral polio vaccine type 2 SIA impact in a large outbreak of circulating vaccine-derived poliovirus in Nigeria. The Journal of infectious diseases (2023)
Michael Famulare, Wesley Wong, Rashidul Haque, James A Platts-Mills, Parimalendu Saha, Asma B Aziz, Tahmina Ahmed, Md Ohedul Islam, Md Jashim Uddin, Ananda Sankar Bandyopadhyay, Mohammed Yunus, Khalequ Zaman, Mami Taniuchi
Multiscale model for forecasting Sabin 2 vaccine virus household and community transmission. PLoS computational biology 17 (12) (2021)
Ananda Sankar Bandyopadhyay, Walter A Orenstein
Assessing and Mitigating Local Vulnerabilities to Completeness of Global Polio Eradication. Journal of the Pediatric Infectious Diseases Society (2021)
G R Macklin, Kathleen M O'Reilly, Nicholas C Grassly, W J Edmunds, O Mach, R Santhana Gopala Krishnan, Arend Voorman, J F Vertefeuille, J Abdelwahab, N Gumede, A Goel, S Sosler, J Sever, Ananda Sankar Bandyopadhyay, Mark A Pallansch, R Nandy, P Mkanda, O M Diop, R W Sutter
Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine. Science (New York, N.Y.) 368 (6489) (2020)
Dominika A Kalkowska, Mark A Pallansch, Amanda Wilkinson, Ananda Sankar Bandyopadhyay, Jennifer L Konopka-Anstadt, Cara C Burns, M Steven Oberste, Steven G F Wassilak, Kamran Badizadegan, Kimberly M Thompson
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain. Risk analysis : an official publication of the Society for Risk Analysis 41 (2) (2020)
Nicolette Angela Zhou, Christine Susan Fagnant-Sperati, Jeffry Hiroshi Shirai, Salmaan Sharif, Sohail Zahoor Zaidi, Lubna Rehman, Jaffer Hussain, Rahim Agha, Shahzad Shaukat, Masroor Alam, Adnan Khurshid, Ghulam Mujtaba, Muhammed Salman, Rana Muhammed Safdar, Abdirahman Mahamud, Jamal Ahmed, Sadaf Khan, Alexandra Lynn Kossik, Nicola Koren Beck, Graciela Matrajt, Humayun Asghar, Ananda Sankar Bandyopadhyay, David Scott Boyle, John Scott Meschke
Evaluation of the bag-mediated filtration system as a novel tool for poliovirus environmental surveillance: Results from a comparative field study in Pakistan. PloS one 13 (7) (2018)
Natalie A Molodecky, Isobel M Blake, Kathleen M O'Reilly, Mufti Zubair Wadood, Rana M Safdar, Amy Wesolowski, Caroline O Buckee, Ananda Sankar Bandyopadhyay, Hiromasa Okayasu, Nicholas C Grassly
Risk factors and short-term projections for serotype-1 poliomyelitis incidence in Pakistan: A spatiotemporal analysis. PLoS medicine 14 (6) (2017)

Ananda Sankar Bandyopadhyay.css-eqlu8i{font-size:small;padding-left:4px;} (A S Bandyopadhyay, Ananda S Bandyopadhyay)

Publication Activity (10 Years)

Top Topics

Top Venues

Ananda Sankar Bandyopadhyay (A S Bandyopadhyay, Ananda S Bandyopadhyay)